Press Releases

Press Releases

Breaking news from across the pharma sector

Austrian State Secretary to speak at FlyPharma Europe 2023Austrian State Secretary to speak at FlyPharma Europe 2023
Austrian State Secretary to speak at FlyPharma Europe 2023

29 September 2023 -- London, UK -- FlyPharma Europe will welcome Mr Florian Tursky, the Austrian state secretary, to the conference on 10 October, where he will deliver an opening speech. He will join a host of expert industry speakers from both pharma and cargo sectors

Sep 28, 2023 Conferences and Events
Revvity Expands Access to Base Editing Technology with Aim to Accelerate Discovery to CureRevvity Expands Access to Base Editing Technology with Aim to Accelerate Discovery to Cure
Revvity Expands Access to Base Editing Technology with Aim to Accelerate Discovery to Cure

26 September 2023 -- Massachusetts, US -- Revvity unveils its groundbreaking Pin-point base editing platform reagents, providing researchers with unparalleled access to implement the advanced gene editing technique in their preclinical laboratories

Sep 25, 2023 Press Releases
Cellectricon Expands Neuroscience Contract Research Portfolio with New Neuroplasticity Services Cellectricon Expands Neuroscience Contract Research Portfolio with New Neuroplasticity Services
Cellectricon Expands Neuroscience Contract Research Portfolio with New Neuroplasticity Services

26 September 2023 -- Molndal, Sweden -- Cellectricon, a services provider dedicated to advancing neuroscience drug discovery, announced the launch of a new service module for neuroplasticity research

Sep 25, 2023 Press Releases
Start Codon Invites Life Sciences Leaders, Founders and Investors to Innovation Showcase 2023Start Codon Invites Life Sciences Leaders, Founders and Investors to Innovation Showcase 2023
Start Codon Invites Life Sciences Leaders, Founders and Investors to Innovation Showcase 2023

26 September 2023 -- Cambridge, UK -- Start Codon, a life science and healthcare venture-building fund, is pleased to invite life sciences leaders, entrepreneurs and investors from across the life science and biotech industries to attend their Innovation Showcase 2023

Sep 25, 2023 Press Releases
Evonetix Unveils New Branding to Align with its Vision for Gene-length DNA SynthesisEvonetix Unveils New Branding to Align with its Vision for Gene-length DNA Synthesis
Evonetix Unveils New Branding to Align with its Vision for Gene-length DNA Synthesis

26 September 2023 -- Cambridge, UK -- Evonetix, the Company developing semiconductor scale technology to improve access to gene synthesis, announces the introduction of new branding to align with its vision to ‘Redefine possible’ through the development and commercialisation of its benchtop semiconductor gene synthesis platform

Sep 25, 2023 Press Releases
Sygnature Discovery Successfully Identifies Potent SHP2 Degrader Compounds Sygnature Discovery Successfully Identifies Potent SHP2 Degrader Compounds
Sygnature Discovery Successfully Identifies Potent SHP2 Degrader Compounds

25 September 2023 -- Nottingham, UK -- Sygnature Discovery and UBE Corporation have begun a collaboration on a Hit-to-Lead programme to identify SHP2 degraders

Sep 24, 2023 Press Releases
 Optibrium Releases Powerful Metabolism Prediction Capability in Next Generation StarDrop Software Optibrium Releases Powerful Metabolism Prediction Capability in Next Generation StarDrop Software
Optibrium Releases Powerful Metabolism Prediction Capability in Next Generation StarDrop Software

25 September 2023 -- Cambridge, UK -- Optibrium, a leading developer of software and AI solutions for drug discovery, launched the latest version of its drug discovery platform, StarDrop 7.5, introducing a powerful module for drug metabolism prediction

Sep 24, 2023 Press Releases
2023 State of Tech in Biopharma Report Reveals Tech Strategies in Era of Data & AI2023 State of Tech in Biopharma Report Reveals Tech Strategies in Era of Data & AI
2023 State of Tech in Biopharma Report Reveals Tech Strategies in Era of Data & AI

21 September 2023 -- London, UK -- Benchling launches its inaugural 2023 State of Tech in Biopharma report. The report surveyed 300 R&D and IT experts from biopharma companies large and small to do a first-ever investigation into biopharma’s use of an enabling tech stack.

Sep 20, 2023 Press Releases
Evecxia Therapeutics & Quotient Sciences Complete Phase I Clinical Milestone in Depression TreatmentEvecxia Therapeutics & Quotient Sciences Complete Phase I Clinical Milestone in Depression Treatment
Evecxia Therapeutics & Quotient Sciences Complete Phase I Clinical Milestone in Depression Treatment

21 September 2023 -- Nottingham, UK -- A drug development partnership between Evecxia Therapeutics and Quotient Sciences has resulted in the successful delivery of a Phase 1 clinical testing program for Evecxia’s drug candidate EVX-101, which is in development for major depressive disorder (MDD)

Sep 20, 2023 Press Releases
 Mural Health Raises $8M Led by Bessemer Venture Partners to Accelerate Growth Mural Health Raises $8M Led by Bessemer Venture Partners to Accelerate Growth
Mural Health Raises $8M Led by Bessemer Venture Partners to Accelerate Growth

19 September 2023 -- Pennsylvania, US -- Mural Health Technologies, a next-generation clinical trial participant management platform, announced that it has raised $8 million in seed funding, led by Bessemer Venture Partners, with participation from Virtue VC, Operator Partners, Arkitect Ventures, Correlation Ventures and Project Mayhem Ventures.

Sep 18, 2023 Press Releases
The Next Generation in Immunoassays Designed to Accelerate Translational ResearchThe Next Generation in Immunoassays Designed to Accelerate Translational Research
The Next Generation in Immunoassays Designed to Accelerate Translational Research

19 September 2023 -- Uppsala, Sweden -- Olink Holding AB announced the introduction of Olink Target 48 Mouse Cytokine Panel, a validated multiplexed protein panel that offers a detailed view of the murine immune system, enabling in-depth disease modelling, longitudinal studies and translational research.

Sep 18, 2023 Press Releases
VHIO Discovers Potential Use of Breast Milk Liquid Biopsy for the Early Diagnosis of Breast CancerVHIO Discovers Potential Use of Breast Milk Liquid Biopsy for the Early Diagnosis of Breast Cancer
VHIO Discovers Potential Use of Breast Milk Liquid Biopsy for the Early Diagnosis of Breast Cancer

14 September 2023 -- Barcelona, UK -- Researchers at VHIO, led by Dr Cristina Saura, head of the VHIO Breast Cancer Group and the Breast Unit at Vall d'Hebron University Hospital, and Dr Ana Vivancos, head of VHIO's Genomics laboratory, has shown for the first time that breast milk from breast cancer patients contains tumour DNA, known as circulating tumour DNA (ctDNA).

Sep 13, 2023 Press Releases